As companies seek to negotiate the volatility of emerging markets, the uncertainties of healthcare reforms, and changing customer demands, accurate forecasting will need to come to the fore as a way to address the changing pharma landscape.
Experts say one of the greatest concerns for the industry is the health of global economies — from lingering concerns related to debt-laden countries in the European Union to trade surpluses fueled by purposefully devalued currencies. The impact of these issues and the stability of global markets and currencies will have significant influence on the…
Related Industry Conference
2012 Healthcare (Pharmaceutical) Industry Perspective
Slowing Growth in Developed Markets
Ken Fyvie. Senior Consultant, the Life-Sciences and Healthcare Practice, PA Consulting, a management and IT consulting and technology firm. For more information, visit paconsulting.com.
Matt Geller, Ph.D. President, Geller Biopharm Inc., a full-service healthcare investment bank. For more information, visit gellerbiopharm.com.
Judith Kulich. Principal, ZS Associates, which provides sales and marketing consulting, outsourcing, technology, and software. For more information, visit zsassociates.com.
Craig Wylie. Senior Consultant in the Life-Sciences and Healthcare Practice, PA Consulting, a management and IT consulting and technology firm. For more information, visit paconsulting.com.